Beetham Thomas W. — SEC Form 4 filings

SEC reporting owner CIK 1741382. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-09-30 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Viridian Therapeutics, Inc.\DE (VRDN)Chief Operating Officer41 leg · 5,000 sh · $117,0508

Form 4 filings — Beetham Thomas W.

FiledFormIssuerReported transactionsSource
2026-03-094/AViridian Therapeutics, Inc.\DE (VRDN)Tax withholding (F): 3,048 @ $30.19EDGAR
2026-03-044Viridian Therapeutics, Inc.\DE (VRDN)Option exercise (M): 9,409 · Tax withholding (F): 3,138 @ $29.32 · Grant/award (A): 176,550 (derivative) @ $0 · Grant/award (A): 35,300 (derivative) @ $0 · Option exercise (M): 9,409 (derivative) @ $0EDGAR
2025-03-044Viridian Therapeutics, Inc.\DE (VRDN)Grant/award (A): 225,814 (derivative) @ $0 · Grant/award (A): 37,636 (derivative) @ $0EDGAR
2024-09-304Viridian Therapeutics, Inc.\DE (VRDN)Purchase (P): 5,000 @ $23.41EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741382 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →